期刊文献+

徐州地区结核分枝杆菌耐多药、广泛耐药情况调查

下载PDF
导出
摘要 目的:分析徐州地区结核分枝杆菌(MTB)临床分离株对一、二线抗结核药物耐药情况,了解本地耐多药结核(MDR-TB)、广泛耐药结核病(XDR-TB)所占比例。方法:对627例涂阳肺结核患者的痰标本采用改良罗氏培养法进行结核分枝杆菌培养,同时对培养出的MTB分别进行异烟肼(H)、利福平(R)、链霉素(S)、乙胺丁醇(E)、丁胺卡那霉素(Amk)、左氧氟沙星(Lfx)药物敏感性试验。结果:比例法检测627株MTB分离株中,单耐63例,多耐28例,耐多药125例,广泛耐药18例。结论:徐州地区耐药情况严重,尤其耐多药、广泛耐药结核病比例较高,为本地区结核病控制增加难度。
出处 《科技信息》 2013年第36期19-19,共1页 Science & Technology Information
基金 江苏省徐州市社会发展项目(编号xm08c042)
  • 相关文献

参考文献5

  • 1徐丽玲,赵根明.耐多药结核病的特点及其控制[J].现代预防医学,2005,32(8):914-915. 被引量:5
  • 2结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 3.Emergence of Mycobacterium tuberculosis with extensiveresistance tosecond-line drugs—worldwide.2000-2004[].Morbidity and Mortality Weekly Report.2006
  • 4World Health Organization.Multidrug and extensively drug-resistant TB (M/XDR-TB).:2010global rePort on surveillance and resPonse[].(WHO/HTM/TB/ ).2010
  • 5CDC.Revised definition of extensively drug-resistan tuberculosis[].Morbidity and Mortality Weekly Report.2006

二级参考文献17

  • 1Dye C, Williams BG, Espinal AM., et al. Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis [J]. Science, 2002, 295: 2042- 2046.
  • 2Cullinan T. Drug-resistant tuberculosis: desperate measure? [J] .The Lancet, 2001, 357: 1124.
  • 3Suarez AG, Floyd K, Portcoarrero J, et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosispatients: a national cohort study in Peru [J]. The Lancet,2002; 359: 181- 190.
  • 4Borgdorff MW, Flord K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low-and middel-income countries[R]. Bulletin of the World Health Organization, 2002; 80 (3): 217-287.
  • 5Tiruviluarnala P, Reichmen LB. Tuberculosis [J]. Annual review of public health, 2002, 23 ( 1 ): 403 - 424.
  • 6Farmer P, Kim JY. Community based approaches to the control of multidrugresistant tuberculosis: introducing "DOTS-plus" [J]. BMJ,1998; 317: 617-670.
  • 7Sterling TR, Lehmann HP, Frieden TR. Impact od DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis [J]. BMJ, 2003; 326: 577-582.
  • 8Ariel PM, GowdaDK, FriedenTR, etal. Controllingmultidrug-resistant tuberculosis and access to expensive drug: arational framework[R]. Bulletin of the World Health Organization, 2002, 80 (6) LA95-496.
  • 9Espinal MA, Zaleski R. TB control and access to second-line drugs:better model needed [R]. Bulletin of the World Health Organization,2002, 80 (6): 494 - 495.
  • 10Suarez PG. First requirement for control of multidrug-resistant TB:realism [R]. Bulletin of the World Health Organization, 2002, 80(6): 495.

共引文献801

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部